Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 生化科學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32036
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor林俊宏(Chun-Hung Lin)
dc.contributor.authorChia-Ling Liuen
dc.contributor.author劉家玲zh_TW
dc.date.accessioned2021-06-13T03:28:56Z-
dc.date.available2006-07-31
dc.date.copyright2006-07-31
dc.date.issued2006
dc.date.submitted2006-07-27
dc.identifier.citation第五章 參考文獻
1. Warren, J. R. and Marchall, B. J. (1993) Lancet 1, 1273-1275
2. Handt, L. K., Fox, J. G., and Dewhirst, F.E., (1994) Infect. Immun. 62, 2367-2374
3. Dore, M.P., Sepulveda A.R., El-Zimaity, H. (2001) Am. J. Gastroenterol 96, 1396-14-1
4. Dubois, A. (1995) Emerg. Infect. Dis 1, 79-85
5. Peterson, W. I. (1991) N. Engl. J. Med. 324, 1043-1048
6. Parsonnet, J. (1996) N. Engl. J. Med. 335, 278-280
7. Nakamura, S. Aoyagi, K., Iida, M., Fujishima, M., and Tsuneyoshi, M. (1997) Cance 79, 3-11
8. Guruge, J.L., Falk, P.G., Lorenz, R.G., Dans, M., Wirth, H.P., Blaser, M.J., Berg, D.E., and Gordon, J.I. (1998) Proc. Natl. Acad. Sci. USA 95, 3925-3930
9. Parsonnet, J., Shmuely, H., and Haggerty, T. (1999) J. Am. Med. Assoc. 282, 2240-2245
10. Yoshiyama, H., and Nakazawa, T. (2000) Microbes and Infection 2, 55-60
11. McGee, D. J., and Mobley, H. L. T. (1999) Curr. Top. Microbiol. Immunol. 241, 155-180
12. Angstrom, J., Teneberg, S. Milh, M. A., Larsson, T., Leonardsson, I., Olsson, B. M., Halvarsson, M. O., Daneilsson, D., Aslund, I. N., Ljungh, A., Wadstrom, T., and Karlsson, K. A. (1998) Glycobiology 8, 297-309
13. Bitzan, M. M., Gold, B. D., Philpott, D. J., Huesca, M., Sherman, P. M., Karch, H., Lissner, R., Lingwood, C. A., and Karmali, M. A. (1998) J. Infec. Dis. 177, 955-961
14. Appelmelk, B. J., Negrini, R., Moran, A. P., and Kuipers, E. J. (1997) Trends in Microbiol. 5, 70-73
15. Cover, T. L., Tummuru, M. K. R., Cao, P., Thompson, S. A., and Blaser, M. J. (1994) J. Biol. Chem. 269, 10566-10573
16. Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappuoli, R., and Ghiara, P. (1995) Science 267, 10566-10573
17. Xiang, Z., Bugnoli, M., Pappuoli, R., Covacci, A., Ponzetto, A., and Crabtree, J. E. (1993) Lancet 341, 900-901
18. Ilver, D., Arnqvist, A., Ogren, J., Frick, I.M., Kersulyte, D., Incecik, E.T., Berg, D.E., Covacci, A., Engstrand, L., and Boren, T. (1998) Science 279, 373-377
19. Guruge, J.L., Falk, P.G., Lorenz, R.G., Dans, M., Wirth, H.P., Blaser, M.J., Berg, D.E., and Gordon, J.I. (1998) Proc. Natl. Acad. Sci. USA 95, 3925-3930.
20. Mahdavi, J., Sonden, B., Hurtig, M., Olfat, F.O., Forsberg, L., Roche, N., Angstrom, J., Larsson, T., Teneberg, S., Karlsson, K.A., Altraja, S., Wadstrom, T., Kersulyte, D., Berg, D.E., Dubois, A., Petersson, C., Magnusson, K.E., Norberg, T., Lindh, F., Lundskog, B.B., Arnqvist, A., Hammarstrom, L., and Boren, T. (2002) Science 297, 573-578.
21. Linden, S., Boren, T., Dubois, A., and Carlstedt, I. (2004) Biochem. J. 379, 765-775.
22. Hynes, S.O., Keenan, J.I., Ferris, J.A., Annuk, H. and Moran A.P. (2005) Helicobacter 10, 146-156
23. Lozniewski, A., Haristoy, X., Rasko, D.A., Hatier, R., Plénat, F., Taylor, D.E., and Angioi-Duprez, K. (2003) Infec. Immun. 71, 2902-2906
24. Teixeira, A., David, L., Reis, C.A., Costa, J., and Sobrinho-Simoes, M. (2002) J. Pathol. 197, 37-43
25. Backstrom, A., Lundberg, C., Kersulyte, D., Berg, D.E, Boren, T., and Arnqvist, A. (2004) Proc. Natl. Acad. Sci. USA 101, 16923-16928.
26. Moran, A.P., Knirel, Y.A., Senchenkova, S.N., Widmalm, G., Hynes, S.O., and Jansson, P.E. (2002) J. Biol. Chem. 277, 5785-95.
27. Tomb, J. F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Doughherty, B. A., Nelson, K., Quackenbush, J., Zhou, L., Kerkness, E.F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H. G., Glodek, A., McKennet, K., Fitzegerald, L. M., Lee, N., Adams, M. D., Hichey, E. K., Berg, D. E., Gocatne, J. D., Utterback, T. R., Peterson, J. D., Kelley, J. M., Cotton, M. D. Weidman, J. M., Fujii, C., Bowman, C., Watthey, L., Williams, S. H., Borodovsky, M., Karp, P. D., Smith, H. O., Fraser, C. M., Venter, and J. C. (1997) Nature 388, 539-547
28. Covacci, A., Telford, J. L., Giudice, G. D., Parsonnet, J., and Rappuoli, R. (1999) Science 284, 1328-1333
29. Sharma, S. A., Tummure, M. K. R., Miller, G.G., and Blaser, M. J. (1995) Infec. Immun. 63, 1681-1687
30. Odenbreit, S., Puls, J., Sedlmaiser, B., Gerland, E., Fischer, W., and Haas, R. (2000) Science 287, 1497-1550
31. Landsteiner, K. (1900) Zbl. Bakt. 27, 357-362
32. Von Decastello, A., and Sturli, A. (1902) Munch Med. Wschr. 49, 1090–1095
33. Hartmann, G. (1941) Group Antigens in Human Organs, Copenhagen Munksgaard
34. Watkins, W.M., and Morgan, W.T.J. (1955) Vox Sang 5, 1–14.
35. Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., and Kimura, N. (2004) Cancer Sci 95, 377-384
36. Saitoh, O., Wang, W. C, Lotan, R., and Fukuda, M. (1992) J. Biol. Chem. 267, 5700-5711
37. Wirth, H. P., Yang, M., Peek Jr, R. M. Tham, K. T., and Blaser, M. J.(1997) Gastroenterology 113, 1091-1098
38. Israel, D. A., Salama, N., Krishna, U., Riger, U. M., Atherton, J.C., Falkow, S., and Peek, R. M. Jr. (2001) Proc. Natl. Acade. Scci USA 98, 14625-14630
39. Taylor, D. E., Wang, G., Zhongming, and G., Rasko, D. A. (2000) Mol. Microbio. 36, 1187-1196
40. Backstrom, A., Lundberg, C., Kersulyte, D., Berg, D.E, Boren, T., and Arnqvist, A. (2004) Proc. Natl. Acad. Sci. USA 101, 16923-8.
41. Moran, A.P., Knirel, Y.A., Senchenkova, S.N., Widmalm, G., Hynes, S.O., and Jansson, P.E. (2002) J. Biol. Chem. 277, 5785-95.
42. Oril, R., Mollicone, R., Cailleau, A., Valanzino, L., and Breton, C. (1999) Glycobiology 9, 323-334
43. Vries, T. D., Knegtel, M. A., Holmes, E. H., and Macher, B. A. (2001) Glycobiology 11, 119R-128R
44. Greenwell, P. (1997) Glycoconjugate J. 14, 159-173
45. Kleene, R., and Berger, E.G. (1993) Biochim. Biophys. Acta. 1154, 283-325.
46. Tayler, D. E., Ma, B., Wang. G., Palcic, M. M., and Hazes, B. (2003) J. Biol. Chem. 278, 21893-21900
47. Wong, C. H., Murrat, B. W., Takayama, S. T., and Schultz, J. (1996) Biochem. 35, 11183-11195
48. Moran, A. P., Prendergast, M. M., and Appelmelk, B. J. (1996) FEMS Immun. Med. Microbiol. 16, 105-115
49. Appelmelk, B.J., Simoons-Smit, I., Negrini, R., Moran A. P., Aspinall, G. O., Forte, J. H., Vries, T. D., Quan, H., Verboo,. T., Maaskant, J. J., Ghiara, P., Kuipers, R. J., Bloemena, E., Tadema, T. M., Townsend, R. R., Tyagarajan, K., Crothers Jr. J. M. Monteiro, M. A. Savio, A., and Graaff, J. D. (1996) Infect. Immun. 64, 2031-2040
50. Taylor, D. E., Ge, Z., Chan, N. E. C., and Palcic, M. W. (1997) J. Biol. Chem. 272, 21357-21363
51. Taylor, D. E., Wang, G., Rasko, D. A., and Sherburne, R. (1999) Mol. Microbiol. 31, 1265-1274
52. Taylor, D. E., Wang, G., Rasko, D. A., and Palcic, M. W. (2000) J. Biol. Chem. 275, 4988-4994
53. Ernst, B., Rabbam, S., Miksa, V., and Wipf, B. (2005) Glycobiology 15, 1076-1083
54. Taylor, D. E., Wang, G., Rasko, D. A., and Palcic, M. M., and Boulton, P. G., (1999) Microbiology 145, 3245-3253
55. Martin, S. L., Edbrooke, M. R., Hodgman, T. C., van den Eijnden, D. H., and Bird, M. I. (1997) J. Biol. Chem. 272, 21349-21356
56. Lin, S.W., Wu, I.L., and Lin, C.H. (2005) Glycoconjugate J. 22, 186.
57. 本實驗室袁翠敏中華民國九十一年六月碩士論文,Cloning and overexpression of α1,3-Fucosyltransfrase from Helicobacter pylori CCRC17026.
58. Taylor, D. E., Palcic, M. M., Haze, B., Ma, B. Wang, G., Rasko, D. A. (2003) J. Biol. Chem. 278, 21893-21900
59. Yamamoto, F., Clausen, H., White, T., Marken, J. and Hakomori, S. (1990) Nature 345, 229-233.
60. Breton, C., Snajdrova, L., Jeanneau, C., Koca, J., and Imberty, A. (2006) Glycobiology 16, 29R-37R
61. Vrielink, A., Rüger, W., Driessen, H. P., and Freemont, P. S. (1994) The EMBO Journal 13, 3413-3422
62. Lesk, A.M. (1995) Curr. Opin. Struct. Biol. 5, 775-783.
63. Davies, J., Charnock, S. J. (1999) Biochemistry 38, 6380-6385
64. Chiu, C.P., Watts, A.G., Lairson, L.L., Gilbert, M., Lim, D., Wakarchuk, W.W., Withers, S.G. and Strynadka, N.C. (2004) Nat. Struct. Mol. Biol. 11, 163- 170.
65. Boix, E., Zhang, Y., Swaminathan, G.J., Brew, K. and Acharya, K.R. (2002) J. Biol. Chem. 277, 28310-28318.
66. Qasba, P. K., Ramakrishnan, B., and Balaji, P. V. (2003) J. Mol. Biol. 318, 491-502
67. Qasba, P.K., Ramakrishnan, B. and Boeggeman, E. (2005) Trends Biochem. Sci. 30, 53-62.
68. Breton, C., Bettler, E., Joziasse, D.H., Geremia, R.A. and Imberty, A. (1998) J. Biochem. 123, 1000-1009.
69. Breton, C. and Imberty, A. (1999) Curr. Opin. Struct. Biol., 9, 563-571
70. Persson, K., Ly, H.D., Dieckelmann, M., Wakarchuk, W.W., Withers, S.G. and Strynadka, N.C.J. (2001) Nat. Struct. Biol. 8, 166-175
71. Boix, E., Zhang, Y., Swaminathan, G.J., Brew, K. and Acharya, K.R. (2002) J Biol Chem, 277, 28310-28318
72. Acharya, K. R., Boix, E., Zhan, Y., Swaminathan, G. J., Brew, K. (2002) J. Biol. Chem. 277, 28310-28318
73. Persson, K., Ly, H.D., Dieckelmann, M., Wakarchuk, W.W., Withers, S.G. and Strynadka, N.C.J. (2001) Nat. Struct. Biol. 8, 166-175.
74. Qasba, P. K., Ramakrishnan, B., Balaji, P. V. (2002) J. Mol. Biol. 318, 491-502
75. Morera, S., Lariviere, L., Gueguen, C. V. (2003) J. Mol. Biol. 330, 1077-1086
76. Morera, S., Lariviere, L.,Kurzeck, J., Aschke-Sonnenborn, U., Freemont, P. S., Janin, J., Ruger, W. (2001) J. Mol. Biol. 311, 569-577
77. Dupuy, D., Germot, A., Julien, R., and Maftah, A. (2004) Glycoconjugate 14, 347-356
78. Larsen, R. D., Ernst, L. K. Nair, R. P. and Lowe, J. B. (1990) Proc. Natl. Acad. Sci. USA 87, 6674-6678
79. Kelly, R. J., Rouquier, S., Giorgi, D., Lennon, G. G., and Lowe, J. B. (1995) J. Biol. Chem. 270, 4640-4649
80. Kukowska-Latallo, J. F., Larsen, R. D., Nair, R. P., and Lowe, J. B. (1990) Genes Dev. 4, 1288-1303
81. Goelz, S. E., Hession C., Goff, D., Griffiths, B., Tizard, R., Newman, B., Chi-Rosso, G., and Lobb, R. (1990) Cell 63, 1349-1356
82. Weston, B.W., Smith, P. L., Kelly, R. J., and Lowe J. B. (1992) J. Biol. Chem. 267, 24575-24584
83. Weston, B. W., Nair, R. P., Larsen, R. D., and Lowe, J. B. (1992) J. Biol. Chem. 267,4152-4160
84. Sasaki, K., Kurata, K., Funayama, K., Nagata, M. Watanabe, E., Ohta, S., Hanai, N., and Nishi, T. (1994) J. Biol. Chem. 269, 14730-14737
85. Yanagidani, S., Uozumi, N., Ihara, Y., Miyoshi, E., Yamaguchi, N., and Taniguchi, N. (1997) J. Biochem. (Tokyo) 121, 626-632
86. Murray, B. W., Wittmann, V., Burkart, M. D., Hung, S. C., and Wong, C. H. (1997) Biochemistry 63, 823-831
87. Dupuy, F., Germot, A., Julien, R., and Maftah A. (2004) Gycobiology 14, 347-356
88. Shao, H., He, X., Achnine, L., Blount, J. W., Dixon, R. A., and Wang, X. (1990) The Plant Cell 17, 3141-3154
89. Jost, F., de Vries, T., Knegtel, R. M. A., and Macher, B. A., (2005) Glycobiology 15, 165-175
90. Ma, B., Lau, L. H., Palcic, M. M., Hazes, B., and Taylor, D. E. (2005) J. Biol. Chem., 280, 36848-36856
91. Zhang, Y., Swaminathan, G. W., Deshpande, A., Boix, E., Natesh, R., Xie, Z., Acharya, K. R., and Brew, K. (2003) Biochemistry 42, 13512-13521
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32036-
dc.description.abstract幽門螺旋桿菌 (Helicobacter pylori,簡稱H. pylori)感染世界上50%的人口,目前被證實感染幽門桿菌會造成消化性潰瘍、胃淋巴瘤等相關疾病。這株致病菌可以在LPS (lipopolysaccharide) 結構末端的O抗原上表現路易士抗原 (Lewis antigen),這種路易士抗原可以在感染週遭的胃上皮細胞看到,如此一來,幽門桿菌就可以藉模擬而躲過宿主細胞的免疫系統攻擊。在路易士抗原合成途徑中,岩藻醣轉移酶負責催化最後幾步的反應,可以將GDP-Fuc的fucose轉移到受質上。α-1,3-fucosyltransferase (簡稱α-1,3-FucT)以LacNAc為受質,經轉糖作用後形成Lex。α-1,3-FucT在C端有兩性螺旋序列,可以幫助蛋白質附著於膜上。本實驗室之前將蛋白質從C端做45個胺基酸的截短,得到水溶性蛋白質。此種長度的截短我們稱之為C45-FucT,與具有全長的α-1,3-FucT得到具有相同的高活性。從兩性螺旋序列往N端找,可以看到十組七個胺基酸的重複序列。C115-FucT從C端截短115個胺基酸,包含兩性螺旋序列與可以形成Leu zipper的組七個胺基酸的重複序列;由於C115-FT失去可以幫助形成雙體的Leucine zipper,故此種長度的截短酵素為單體且活性下降到6.5 %。
由於缺乏FucT的結構資訊,所以要了解此酵素的活性區與催化機制,是件不容易的事。利用化學修飾法找出His和Arg可能參與受質的結合後,我們將10個His與10個Arg分別利用定點突變並做活性測試,討論與GDP-Fuc和LacNAc結合有關的胺基酸。
DEPC (diethylpyrocarbonate) 和PGO (phenylglycoxal) 分別會與His和Arg形成共價鍵進而抑制酵素反應。但是當α-1,3-FucT先與GDP-Fuc結合達到保護donor sugar結合區後,再加入DEPC或PGO,抑制的效果卻會大大減低。由於GDP-Fuc的保護作用,我們可以推測在GDP-Fuc結合區,有某些His和Arg幫助GDP-Fuc跟蛋白質結合。
我們將C45-FucT的10個Arg與10個His突變成Ala並分別測試活性。活性測試是利用FucT的副產物GDP的生成量會造成NADH的減少,藉由測量NADH的量而達到測試FucT活性的目的。其中R79A、 R118A、R180A、R195A 和R354A的突變株活性完全消失,這五個胺基酸對α-1,3-FucT的活性是非常重要的。R89A、H60A、H131A、H282A、H298A和H345A則是有活性下降。我們將這六個活性下降的突變株更進一步測Km。由Km的數據得知H282、H298和H354會幫助GDP-Fuc結合;H60與R89會幫助LacNAc結合。
最近,王惠鈞教授實驗室將FucT做出結晶解出結構。目前為止只有C115-FucT這種截短的酵素可以得到結晶。從結構上,我們看到R195、N240、E249和K250會直接跟GDP-Fuc有氫鍵結合。但是在活性測試的實驗中卻發現N240會幫助LacNAc與酵素作用。利用結構疊合,我們推斷E95為catalytic base。另外藉由酵素動力學測試和C115-FucT的結構,我們推測出更接近野生型α-1,3-FucT的反應機制與構型。
zh_TW
dc.description.abstractHelicobacter pylori (H. pylori) is considered to be a primary cause of gastritis, duodenal ulcer and gastric cancer. This pathogenic bacterium produces Lex and Ley epitopes in the O-antigens of lipopolysaccharides (LPS) to mimic the carbohydrate antigens on the surface of gastric epithelial cells. The molecular mimicry avoids the detection by the host immune system. The enzyme α-1,3-fucosyltransferase (α1,3-FucT) from H. pylori catalyzes the glycosyl addition of fucose from the donor GDP-fucose to the acceptor LacNAc. It is a membrane associated protein. Previously, our lab carried out a systematic truncation of the C terminus of the α-1,3-FucT to improve the protein solubility. C-Terminal 45 amino acid residues include the amphiphilic helices that anchor the protein to the cell membrane. The corresponding protein, C45-FucT, was water soluble and had the same activity as that of the full-length enzyme. Next to the amphiphilic helices is the heptad repeats. Deletion of 115 residues removed both helices and the heptad repeats in the C terminal end. Because heptad repeats were expected to form the leucine zipper and facilitated the formaitnon of a dimeric structure, therefore C115-FucT was found to be a monomer with low activity.
Due to lack of structural imformation of fucosyltransferase, it is not easy to understand the catalytic mechanism. In order to study the residues involed in catalysis and substrate binding, this thesis lays a special emphasis on His and Arg. The methods include the use of modifiers and preparation of different mutant proteins by site-directed mutagenesis.
DEPC (diethylpyrocarbonate) and PGO (phenylglycoxal) were shown to specifically react with His and Arg, respectively. Both of these modifier can inactivate the α-1,3-FucT of H. pylori. When α-1,3-FucT was incubated with GDP-Fuc before the addition of PGO or DEPC, the higher concentration of GDP-Fuc was used in the study, the higher level of activity was retained. The protection effect of GDP-Fuc indicated that His and Arg were likely located at either the active site or the binding site of the donor substrate.
Ten Arg residues and ten His residues were individually mutated to Ala and the resulting mutants were analyzed by the activity assay. The activity assay was a coupling assay carried out based on the production of the side product GDP. The result indicated the mutants R79A, R118A, R180A, R195A and R354A were completely inactive. R89A, H60A, H131A, H282A, H298A and H345A were found to have reduced activities. The Km and Vmax of these mutants were also measured. According to Km, H282, H298 and H354 were found to be involved in the binding with GDP-Fuc, Whereas H60 and R89 were related to the binding with LacNAc.
The structure of was solved by x-ray crystallograpgy in the collaboration with Dr. Andrew Wang’s group of this institute. So far only C115-FucT can be crystallized for prove the structural imformation. The results suggest that R195, N240, E249, K250 directly interact with GDP-Fuc. In contrast, the kinetic analysis supports the idea that N240 is involved in the binding with LacNAc. The superimposition of C115-FucT to the structure of BGT (β-Glucosyltransferase) revealed that E95 may act as the catalytic base in general catalytic base. We also try to figure out the real structure of the C45-FucT.
en
dc.description.provenanceMade available in DSpace on 2021-06-13T03:28:56Z (GMT). No. of bitstreams: 1
ntu-95-R92b46026-1.pdf: 5807390 bytes, checksum: 37dd0c982cbd3c459cee46304d8fefc6 (MD5)
Previous issue date: 2006
en
dc.description.tableofcontents目 錄
目錄 I
縮寫表 1
中文摘要 3
英文摘要 5
第一章 序論 7
1. 幽門螺旋桿菌 7
1. 幽門螺旋桿菌之簡介 7
2. 幽門螺旋桿菌之感染 7
2. 路易士抗原 8
1. 血型抗原與路易士抗原 8
2. 血型抗原與癌症 9
3. 幽門螺旋桿菌與路易士抗原 9
3. 岩藻醣轉移酶 10
1. 岩藻醣轉移酶的簡介 10
2. 人類α-1,2-FucT與α-1,6-FucT 11
3. 人類α-1,3-FucT、α-1,4-FucT與α-1,3/4-FucT 11
4. 幽門螺旋桿菌的α-1,2-FucT 12
5. 幽門螺旋桿菌的α-1,3-FucT、α-1,4-FucT、α-1,3/4-FucT 12
4. 醣轉移酶與其結構 14
1. 醣轉移酶與分類法 14
2. 醣轉移酶的二極與三極結構 15
3. GT-A superfamily 與CstII 15
4. GT-B superfamily 16
5. 實驗動機與目的 19
第二章 材料與方法 21
1. 實驗材料 21
2. 實驗之儀器設備 21
3. 分子生物學實驗 22
4. 定點突變基因的建構 23
5. 蛋白質之表現 25
6. 蛋白質之純化 25
7. 蛋白質之鑑定 27
8. 酵素活性與動力學之分析 28
第三章 實驗結果 31
1. 二級結構比對與以結構決定重要之胺基酸與設計突變用引子 31
2. 定點突變株之建構結果 31
3. 蛋白質表現與純化之結果 32
4. His與Arg突變蛋白質活性分析之結果 32
5. 與GDP-Fuc結合之重要胺基酸的突變蛋白質活性分析之結果 33
6. Km與Vmax的酵素動力學測試 33
7. Catalytic base的酵素動力學研究 34
第四章 結果與討論 35
1. 利用化學修飾劑作用與胺基酸突變來研究岩藻醣轉移酶 35
2. 蛋白質結構 37
3. catalytic base與α-1,3-FucT的催化機制 40
4. 整體活性區與蛋白質結構之探討 40
第五章 參考文獻 87

圖次
圖一、A、B、H determinant之結構 43
圖二、第一型與第二型之路易士抗原結構 44
圖三、真核生物與原核生物岩藻醣轉移酶之比較 45
圖四、α-1,2-FucT與α-1,6-FucT之相似序列 46
圖五、α-1,3-FucT之相似序列 47
圖六、推測FucT-V的催化機制 48
圖七、人類與幽門螺旋桿菌合成路易士抗原之途徑 49
圖八、LPS之結構 50
圖九、α-1,3-FucT不同的截短形式與結構卡通圖 51
圖十、幽門螺旋桿菌α-1,3-FucT與α-1,3/4-FucT之胺基酸序列比較 52
圖十一、Rossmann-type fold 53
圖十二、醣轉移酶之結構 54
圖十三、GT-A的催化機制 55
圖十四、BGT的蛋白質結構 56
圖十五、定點突變基因的建構 57
圖十六、BGT與C115-FucT的superimpose 58
圖十七、C115-FucT的結構 59
圖十八、以NADH為基礎並偶合丙酮酸激酶/乳酸脫氫酶的螢光測試 60
圖十九、GDP-Fuc的結合胺基酸 61
圖二十、PGO與C45-FucT作用 62
圖二十一、DEPC與C45-FucT作用 63
圖二十二、比較BGT與C115-FucT之兩個Rossmann-type fold結構 64
圖二十三、motif在人類 FucT-VI與H. pylori C45-FucT之突變株活性比較 65
圖二十四、H. pylori α-1,3-FucT的催化機制 66
圖二十五、與GDP-Fuc結合有關的胺基酸 67
圖二十六、與LacNAc結合有關的胺基酸 68
圖二十七、推測C45-FucT的結構修正 69
表次
表一、幽門螺旋桿菌與其表現之路易士抗原 71
表二、人類岩藻糖轉移酶 72
表三、目前已發表之醣轉移酶結構 73
表四、引子序列表 74
表五、GT結構的分類與預測 76
表六、與GDP-Fuc有氫鍵之胺基酸 77
表七、Arg與His突變株活性測試百分比 78
表八、和GDP-Fuc有氫鍵結合的突變株與catalytic base的活性測試百分比 79
表九、與GDP-Fuc的Km有改變的突變株 80
表十、與LacNac的Km有改變的突變株 81
附錄
附錄一、NCTC 11639 Helicobacter pylori α1,3-FT之基因序列 83
附錄二、NCTC 11639 Helicobacter pylori α1,3-FT之基因序列 84
dc.language.isozh-TW
dc.title利用定點突變研究幽門螺旋桿菌的岩藻糖轉移酶之活性區zh_TW
dc.titleStudy the active site of Helicobactor pylori
α-1,3-fucosyltransferase by site-directed mutagenesis
en
dc.typeThesis
dc.date.schoolyear94-2
dc.description.degree碩士
dc.contributor.oralexamcommittee邱式鴻,邱繼輝,陳玉如
dc.subject.keyword幽門螺旋桿菌,岩藻榶轉移&#37238,zh_TW
dc.subject.keywordHelicobacter pylori,fucosyltransferase,en
dc.relation.page92
dc.rights.note有償授權
dc.date.accepted2006-07-28
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept生化科學研究所zh_TW
顯示於系所單位:生化科學研究所

文件中的檔案:
檔案 大小格式 
ntu-95-1.pdf
  目前未授權公開取用
5.67 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved